Dr Feifel and Dr Dan Press (Harvard Neurology) presents on latest TMS developments
Therapeutic ketamine
Our treatment rooms reflect 11 years of experience in optimizing outcomes
Paper written by Dr. Feifel and colleagues is the most cited in history of Western Journal of Emergency Medicine.
Dr. Feifel Lectures at the largest annual psychopharmacology update conference in the U.S.
Dr. Feifel teaching TMS fundamentals to young resident doctors
Dr. Feifel giving lecture on TMS to physicians at TMS conference
Dr Feifel with Tom Insel (former head of NIMH) and Paul Dugum of Mindstrong after discussing joint research projects
Dr. Feifel with group of visiting physicians from China
Opening day
Dr. Feifel discussing Kadima and new brain treatments on “San Diego Tonight” with Joe Vecchio
We us the latest technology. Our CT system monitors patients' vital signs wirelessly so they can experience the therapeutic effects of ketamine without intrusions.
We feel strongly that patients should understand their treatments and that good treatment involves open communication between the doctor and patient.
Neosync and Kadima have launched a collaboration to research a potential new type of TMS system that normalizes the electrical rhythms (alpha waves) in patients with psychiatric conditions
Dr. Feifel’s Laboratory Developing New Brain Treatments
Dr. Feifel’s Laboratory Developing New Brain Treatments
Dr. Feifel’s Laboratory Developing New Brain Treatments
